![]() Haag D, Feichter G, Goerttler K, Kaufmann M: Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas. Gnant MFX, Blijham GH, Reiner A, Reiner G, Reynders M, Schutte B, van Asche C, Steger G, Jakesz R: DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04. Acta Oncologica 31:157–165, 1992įerno M, Baldetorp B, Ewers SB, Idvall I, Olsson H, Sigurdsson H, Killander D: One or multiple samplings for flow cytometric DNA analyses in breast cancer - prognostic implications? Cytometry 13:241–249, 1992įisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, Siderits R: DNA flow cytometric analysis of primary operable breast cancer. Cancer 62:521–530, 1988įerno M, Baldetorp B, Borg A, Olsson H, Sigurdsson H, Killander D: Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Cancer 62:331–341, 1988įallenius AG, Franzen S, Auer GU: Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. Int J Cancer 51:555–561, 1992įallenius AG, Auer GU, Carstensen JM: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Br J Surg 74:133–136, 1987Įskelinen M, Lipponen P, Papinaho S, Aaltomaa S, Kosma V-M, Klemi P, Syrjanen K: DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Cancer Res 44:4187–4196, 1984ĭowle CS, Owainati A, Robins A, Burns K, Ellis IO, Elston CW, Blamey RW: Prognostic significance of the DNA content of human breast cancer. Cytometry 1987 8:225–234.Ĭoulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. N Engl J Med 320:627–633, 1989Ĭornelisse CJ, van de Velde CJ, Caspers RJ, Moolenaar AJ, Hermans J: DNA ploidy and survival in breast cancer patients. J Clin Oncol 10:428–432, 1992Ĭlark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. Brit J Cancer 62:142–146, 1990Ĭlark GM, Mathieu MC, Owens MA, Dressler LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, et al: Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. Int J Cancer 45:34–39, 1990īlanco G, Holli K, Heikkinen M, Kallioniemi OP, Taskinen P: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological grading. Brit J Cancer 64:139–143, 1991īeerman H, Kluin M, Hermans J, van de Velde CJH, Cornelisse CJ: Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Cytometry 12:147–154, 1991īeerman H, Bonsing BA, van de Vijver MJ, Hermans J, Kluin PM, Caspers RJ, van de Velde CJ, Cornelisse CJ: DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy. Brit J Cancer 55:553–560, 1987īeerman H, Smit VT, Kluin PM, Bonsing BA, Hermans J, Cornelisse CJ: Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Laboratory Investigation 64:215–223, 1991īaildam AD, Zaloudik J, Howell A, Barnes DM, Turnbull L, Moore M, Sellwood RA: DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Cancer Research 44:394–396, 1984īaak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS: Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer. Auer G, Eriksson E, Azavedo E, Caspersson T, Wallgren A: Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |